Skip to main
ISRG

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 24 analyst ratings
Buy
Strong Buy 42%
Buy 46%
Hold 13%
Sell 0%
Strong Sell 0%

Bulls say

Intuitive Surgical is primarily driven by its dominant position in the under-penetrated robotics market, with its pioneering use of robotic systems and a growing number of installations worldwide. The company's recent launch of the next-generation DV5 robotic system is expected to drive continued above-average growth. Despite competition emerging in the U.S. and other markets, ISRG's 20-year+ head start and strong value offered to customers provide a sustainable advantage in the market. The company's recent solid Q2 results, with strong revenue and procedure growth, further reinforce this outlook.

Bears say

Intuitive Surgical is facing potential challenges ahead, with slower growth rates in procedures and installed bases, potential margin pressure from investments in innovation, and potential risks from competition, slower new product adoption, and delays in new product approvals. These factors could lead to a less dramatic growth and earnings potential compared to previous years, and the risks posed by the global healthcare system, changing preferences for purchasing, and government policies in China could further impact the company's performance and outlook.

Intuitive Surgical (ISRG) has been analyzed by 24 analysts, with a consensus rating of Buy. 42% of analysts recommend a Strong Buy, 46% recommend Buy, 13% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 24 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $535.08, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $535.08, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.